Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
My Terrifying Journey To A Diagnosis.
Journal: Journal of general internal medicine
Published: May 31, 2021
Subcutaneous dosing regimens of tocilizumab in children with systemic or polyarticular juvenile idiopathic arthritis.
Journal: Rheumatology (Oxford, England)
Published: July 28, 2020
Efficacy and Safety of Tocilizumab for Polyarticular-Course Juvenile Idiopathic Arthritis in the Open-Label Two-Year Extension of a Phase III Trial.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: May 15, 2020
Neutropenia During Tocilizumab Treatment Is Not Associated with Infection Risk in Systemic or Polyarticular-course Juvenile Idiopathic Arthritis.
Journal: The Journal of rheumatology
Published: December 19, 2018
Growth During Tocilizumab Therapy for Polyarticular-course Juvenile Idiopathic Arthritis: 2-year Data from a Phase III Clinical Trial.
Journal: The Journal of rheumatology
Published: February 16, 2018
Incidence of Gastrointestinal Perforations in Patients with Rheumatoid Arthritis Treated with Tocilizumab from Clinical Trial, Postmarketing, and Real-World Data Sources.
Journal: Rheumatology and therapy
Published: June 04, 2016
Catch-up growth during tocilizumab therapy for systemic juvenile idiopathic arthritis: results from a phase III trial.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: March 14, 2014
Showing 1-7 of 7
Last Updated: 09/26/2026